全文获取类型
收费全文 | 3425篇 |
免费 | 323篇 |
国内免费 | 196篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 48篇 |
妇产科学 | 27篇 |
基础医学 | 457篇 |
口腔科学 | 55篇 |
临床医学 | 412篇 |
内科学 | 624篇 |
皮肤病学 | 64篇 |
神经病学 | 290篇 |
特种医学 | 102篇 |
外国民族医学 | 1篇 |
外科学 | 335篇 |
综合类 | 429篇 |
一般理论 | 2篇 |
预防医学 | 221篇 |
眼科学 | 69篇 |
药学 | 306篇 |
5篇 | |
中国医学 | 107篇 |
肿瘤学 | 334篇 |
出版年
2024年 | 12篇 |
2023年 | 47篇 |
2022年 | 133篇 |
2021年 | 152篇 |
2020年 | 99篇 |
2019年 | 106篇 |
2018年 | 134篇 |
2017年 | 85篇 |
2016年 | 95篇 |
2015年 | 154篇 |
2014年 | 158篇 |
2013年 | 157篇 |
2012年 | 197篇 |
2011年 | 267篇 |
2010年 | 160篇 |
2009年 | 128篇 |
2008年 | 150篇 |
2007年 | 176篇 |
2006年 | 191篇 |
2005年 | 183篇 |
2004年 | 144篇 |
2003年 | 134篇 |
2002年 | 121篇 |
2001年 | 90篇 |
2000年 | 76篇 |
1999年 | 105篇 |
1998年 | 50篇 |
1997年 | 47篇 |
1996年 | 38篇 |
1995年 | 25篇 |
1994年 | 21篇 |
1993年 | 20篇 |
1992年 | 37篇 |
1991年 | 34篇 |
1990年 | 34篇 |
1989年 | 20篇 |
1988年 | 20篇 |
1987年 | 18篇 |
1986年 | 11篇 |
1985年 | 7篇 |
1984年 | 11篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1975年 | 5篇 |
1974年 | 6篇 |
1973年 | 10篇 |
1966年 | 5篇 |
排序方式: 共有3944条查询结果,搜索用时 15 毫秒
101.
Elif Doğan Baki Mustafa Aldemir Serdar Kokulu Halit Buğra Koca Yüksel Ela Remziye Gül Sıvacı Nilgün Kavrut Öztürk Mustafa Emmiler Fahri Adalı Hanife Uzel 《Inflammation》2013,36(6):1327-1333
Cardiopulmonary bypass (CPB) contributes to the secretion of anti-inflammatory cytokines that mediate the inflammatory response observed during open heart surgery. In addition to many factors, type of anesthesia management affects immune response and central nervous system in cardiac surgery. The aim of this study was to assess the effect of propofol versus desflurane anesthesia on systemic immune modulation and central nervous system on patients undergoing coronary artery bypass grafting. Forty patients undergoing elective coronary artery bypass graft surgery with CPB were included in this prospective randomized study. Patients were allocated to receive propofol (n?=?20) or desflurane (n?=?20) for maintenance of anesthesia. The blood samples for IL-6, IL-8, TNF-α, and S100β were drawn just prior to the operation before the induction of anesthesia, second before cardiopulmonary bypass, third after CPB, fourth 4 h postoperatively at the ICU. Major finding in our study is that S100β levels were lower in propofol group when compared to desflurane anesthesia. And also immune reaction was less in patients exposed to desflurane anesthesia when compared to propofol anesthesia as indicated by lower plasma concentrations of IL-8 and IL-6. Propofol is more preferable in terms of S100β for anesthetic management for CABG. 相似文献
102.
103.
104.
105.
Numerical and In Vitro Investigation of a Novel Mechanical Circulatory Support Device Installed in the Descending Aorta
下载免费PDF全文
![点击此处可从《Artificial organs》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Mohammad Amin Rezaienia Akbar Rahideh Borhan Alhosseini Hamedani Dawid Emanuel Maximilian Bosak Silviya Zustiak Theodosios Korakianitis 《Artificial organs》2015,39(6):502-513
Traditional implantation techniques of assist devices from the apex of left ventricle to the ascending or descending aorta are highly invasive and carry substantial complications for end‐stage heart failure patients. This study has shown that the descending aorta can be a promising location to install an implantable mechanical circulatory support with minimally invasive surgery. Herein, the hemodynamic effect of an in‐house prototyped pump implanted in the descending aorta was investigated numerically as well as experimentally. The objective of the experimental study is met by using the in‐house simulator of the cardiovascular loop replicating congestive heart failure conditions. The objective of the numerical study was met by using the modified version of the concentrated lumped parameter model developed by the same team. The results show that the pump placement in the descending aorta can lead to an improvement in pulsatility. The pressure drop, generated at the upstream of the pump, facilitates the cardiac output as a result of after‐load reduction, but at the same time, it induces a slight drop in the carotid as well as the coronary perfusion. The pressure rise, generated at the downstream of the pump, improves the blood perfusion in the renal circulation. 相似文献
106.
107.
Pullarkat VA Bueso-Ramos C Lai R Kroft S Wilson CS Pullarkat ST Bu X Thein M Lee M Brynes RK 《American journal of hematology》2003,73(1):12-17
The majority of patients with systemic mastocytosis with associated clonal, hematological non-mast cell lineage disease (SM-AHNMD) have a myeloid stem cell malignancy including myelodysplastic syndromes (MDS), myelodysplastic/myeloproliferative disorders, acute myeloid leukemia (AML), or chronic myeloproliferative disease. The clinicopathologic features of SM-AHNMD have not been fully characterized. We describe seven cases of this entity: 3 with MDS, 3 with AML, and 1 with chronic myelomonocytic leukemia. In the majority of cases, SM was diagnosed concurrently with the myeloid malignancy and aberrant mast cell morphology was observed. The commonly described c-kit enzymatic site mutation Asp816Val was detected only in 2 cases, while 3 patients carried the Asp816His mutation. Among the 3 cases with AML, 2 patients carried the translocation t(8;21). On the basis of our results and other reported cases, there appears to be a specific association between SM and AML with t(8;21). Concurrent occurrence of SM may define a subset of patients with de novo AML and other myeloid malignancies who have an adverse prognosis. As clinically effective tyrosine kinase inhibitors that inhibit enzymatic-type c-kit mutations are being developed, detection of mast cell proliferation associated with myeloid malignancy may have important therapeutic implications. 相似文献
108.
109.
Sang Kyung Jung Kyung-Ah Kim So Young Ha Hyun Kyo Lee Young Doo Kim Bu Hyun Lee Woo Hyun Paik Jong Wook Kim Won Ki Bae Nam-Hoon Kim June Sung Lee Yoon Jung Jwa 《Clinical and molecular hepatology》2015,21(1):41-48
Background/Aims
This study investigated the antiviral effects of tenofovir disoproxil fumarate (TDF) monotherapy in nucleos(t)ide analogue (NA)-naive and NA-experienced chronic hepatitis B (CHB) patients.Methods
CHB patients treated with TDF monotherapy (300 mg/day) for ≥12 weeks between December 2012 and July 2014 at a single center were retrospectively enrolled. Clinical, biochemical, and virological parameters were assessed every 12 weeks.Results
In total, 136 patients (median age 49 years, 96 males, 94 HBeAg positive, and 51 with liver cirrhosis) were included. Sixty-two patients were nucleos(t)ide (NA)-naïve, and 74 patients had prior NA therapy (NA-exp group), and 31 patients in the NA-exp group had lamivudine (LAM)-resistance (LAM-R group). The baseline serum hepatitis B virus (HBV) DNA level was 4.9±2.3 log IU/mL (mean±SD), and was higher in the NA-naïve group than in the NA-exp and LAM-R groups (5.9±2.0 log IU/mL vs 3.9±2.0 log IU/mL vs 4.2±1.7 log IU/mL, P<0.01). The complete virological response (CVR) rate at week 48 in the NA-naïve group (71.4%) did not differ significantly from those in the NA-exp (71.3%) and LAM-R (66.1%) groups. In multivariate analysis, baseline serum HBV DNA was the only predictive factor for a CVR at week 48 (hazard ratio, 0.809; 95% confidence interval, 0.729-0.898), while the CVR rate did not differ with the NA experience.Conclusions
TDF monotherapy was effective for CHB treatment irrespective of prior NA treatment or LAM resistance. Baseline serum HBV DNA was the independent predictive factor for a CVR. 相似文献110.